Predicting Early Viral Control Under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.00146
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Oral Direct-Acting Antiviral Therapy for Hepatitis C

Journal of Antivirals & Antiretrovirals
2012English

Letter: Hepatitis B Virus Reactivation in Patients With Chronic Hepatitis C During Direct-Acting Anti-Viral Therapy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Digestive Diseases and Sciences
PhysiologyGastroenterology
2011English

Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy

Hepatology
MedicineHepatology
2017English

Direct-Acting Antiviral Drugs and Hepatitis C Virus: A Therapeutic Revolution?

Cancer
Cancer ResearchOncology
2015English

Development of Proteinuria and Focal Segmental Glomerulosclerosis During Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection

Hepatology
MedicineHepatology
2017English

Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct-Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Clinical Outcomes of Direct-Acting Antiviral Therapy in Patients With Compensated Hepatitis C Virus-Related Cirrhosis

Hepatoma Research
2017English

Make Platelet Count Great Again: Direct‐acting Antiviral Agent Therapy in Patients With Chronic Hepatitis C

Advances in Digestive Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy